Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
NCT ID: NCT01540643
Last Updated: 2017-01-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
600 participants
OBSERVATIONAL
2012-03-31
2016-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Zenith® Low Profile AAA Endovascular Graft
NCT02535065
Zenith(R) Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Clinical Study
NCT00875563
Zenith® AAA Endovascular Graft Clinical Study
NCT00196092
Zenith® Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Continued Access Study
NCT02577562
Zenith(R) Low Profile AAA Endovascular Graft Clinical Study
NCT00833924
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Abdominal aortic aneurysm
Iliac Leg Graft
Zenith® Spiral-Z® AAA Iliac Leg Graft
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Iliac Leg Graft
Zenith® Spiral-Z® AAA Iliac Leg Graft
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cook Group Incorporated
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Thomas Lindsay
Role: PRINCIPAL_INVESTIGATOR
Toronto General Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Valley Vascular Consultants
Huntsville, Alabama, United States
University of Colorado, Anschutz Medical Campus
Aurora, Colorado, United States
Hartford Hospital
Hartford, Connecticut, United States
University of Florida
Gainesville, Florida, United States
University of Miami Hospital
Miami, Florida, United States
Mount Sinai Medical Center
Miami Beach, Florida, United States
University Hospital
Augusta, Georgia, United States
Missouri Heart Center
Columbia, Missouri, United States
Mercy Hospital Springfield
Springfield, Missouri, United States
St. Vincent's Heart and Vascular Center
Billings, Montana, United States
Hackensack University Medical Center
Hackensack, New Jersey, United States
Morristown Medical Center
Morristown, New Jersey, United States
Robert Wood Johnson University Hospital
New Brunswick, New Jersey, United States
Albany Medical Center Hospital
Albany, New York, United States
Westchester Medical Center
Hawthorne, New York, United States
Mount Sinai Hospital
New York, New York, United States
Wake Forest Baptist Medical Center
Winston-Salem, North Carolina, United States
Mount Carmel East
Columbus, Ohio, United States
Bend Memorial Clinic
Bend, Oregon, United States
St. Luke's University Hospital
Bethlehem, Pennsylvania, United States
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States
Physican's Regional Medical Center
Knoxville, Tennessee, United States
Houston VA
Houston, Texas, United States
University of Utah Hospital
Salt Lake City, Utah, United States
Providence Regional Medical Center Everett
Everett, Washington, United States
Charleston Area Medical Center
Charleston, West Virginia, United States
Froedert Hospital
Milwaukee, Wisconsin, United States
Hamilton General Hospital
Hamilton, Ontario, Canada
London Health Sciences Centre
London, Ontario, Canada
Ottawa Hospital Civic Campus
Ottawa, Ontario, Canada
Toronto General Hospital
Toronto, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Lindsay T, Jazaeri O, Sherman SM, Saunders AT, Forbes TL; Spiral-Z Registry Investigators. Final results from a postmarket registry of an iliac leg graft with a continuous, spiral nitinol stent. J Vasc Surg. 2020 Aug;72(2):576-583.e1. doi: 10.1016/j.jvs.2019.10.078. Epub 2020 Jan 19.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
11-015
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.